Dorothy P. Kramer

FDA investigator

Appears on 9 documents from 2022 to 2025, mostly at sites in Florida. Most often cites responsibilities of quality control unit (21 CFR 211.22(d)).

9
Documents on file
4.2
Observations per 483
2022
First seen
2025
Most recent

What they cite most

From 38 observations

Activity by year

2022: 3, 2023: 3, 2024: 2, 2025: 1

Where

Florida 5 · North Carolina 1 · Oklahoma 1 · South Carolina 1 · Spain 1

Is Dorothy P. Kramer coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

9 documents, newest first
FirmOpen
483 DOH Central PharmacyJul 28, 2025 · Tallahassee, Florida
483 SmartScience Laboratories, Inc.Nov 22, 2024 · Tampa, Florida
483 Kesin PharmaJan 19, 2024 · Oldsmar, Florida
483 Halocarbon Life Sciences, LLCNov 3, 2023 · North Augusta, South Carolina
483 Rovi Pharma Industrial Services S.A.Sep 22, 2023 · San Sebastian De Los Reyes, Spain
483 King Bio IncJul 28, 2023 · Asheville, North Carolina
483 RAPHA Health Network International, IncDec 16, 2022 · Doral, Florida

About this profile

What does Dorothy P. Kramer inspect?

Dorothy P. Kramer appears on 9 documents on file covering 9 sites, mostly in Florida.

What do they cite most often?

21 CFR 211.22(d) (responsibilities of quality control unit), followed by 21 CFR 211.100(a) and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Dorothy P. Kramer is dated Jul 28, 2025.